The DOI matches its Crossref record; 149 of the 149 references it cites were found in a registry or an index.
Drug combinations: a strategy to extend the life of antibiotics in the 21st century
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Construction of Escherichia coli K‐12 in‐frame, single‐gene knockout mutants: the Keio collection
Baba, T., Ara, T., Hasegawa, M., Takai, Y., Okumura, Y., Baba, M., Datsenko, K. A., Tomita, M., Wanner, B. L., & Mori, H. (2006) · Molecular Systems Biology · doi:10.1038/msb4100050 · Cited by 7,858
Tacconelli, E., Carrara, E., Savoldi, A., Harbarth, S., Mendelson, M., Monnet, D. L., Pulcini, C., Kahlmeter, G., Kluytmans, J., Carmeli, Y., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30753-3 · Cited by 6,142
Functional organization of the yeast proteome by systematic analysis of protein complexes
Gavin, A.-C., Bösche, M., Krause, R., Grandi, P., Marzioch, M., Bauer, A., Schultz, J., Rick, J. M., Michon, A.-M., Cruciat, C.-M., et al. (2002) · Nature · doi:10.1038/415141a · Cited by 4,759
Wang, M., Carver, J. J., Phelan, V. V., Sanchez, L. M., Garg, N., Peng, Y., Nguyen, D. D., Watrous, J., Kapono, C. A., Luzzatto-Knaan, T., et al. (2016) · Nature Biotechnology · doi:10.1038/nbt.3597 · Cited by 4,629
Network pharmacology: the next paradigm in drug discovery
Hopkins, A. L. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.118 · Cited by 4,622
Antibiotic resistance-the need for global solutions
Laxminarayan, R., Duse, A., Wattal, C., Zaidi, A. K. M., Wertheim, H. F. L., Sumpradit, N., Vlieghe, E., Hara, G. L., Gould, I. M., Goossens, H., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70318-9 · Cited by 4,439
Self-citationSystematic identification of protein complexes in Saccharomyces cerevisiae by mass spectrometry
Ho, Y., Gruhler, A., Heilbut, A., Bader, G. D., Moore, L., Adams, S.-L., Millar, A., Taylor, P., Bennett, K., Boutilier, K., et al. (2002) · Nature · doi:10.1038/415180a · Cited by 3,601
Self-citationBioactive Microbial Metabolites: A Personal View
Bérdy, J. (2005) · The Journal of Antibiotics · doi:10.1038/ja.2005.1 · Cited by 3,170
Global landscape of protein complexes in the yeast Saccharomyces cerevisiae
Krogan, N. J., Cagney, G., Yu, H., Zhong, G., Guo, X., Ignatchenko, A., Li, J., Pu, S., Datta, N., Tikuisis, A. P., et al. (2006) · Nature · doi:10.1038/nature04670 · Cited by 2,952
Combination therapy in combating cancer
Mokhtari, R. B., Homayouni, T. S., Baluch, N., Morgatskaya, E., Kumar, S., Das, B., & Yeger, H. (2017) · Oncotarget · doi:10.18632/oncotarget.16723 · Cited by 2,543
Drugs for bad bugs: confronting the challenges of antibacterial discovery
Payne, D. J., Gwynn, M. N., Holmes, D. J., & Pompliano, D. L. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2201 · Cited by 2,512
Synergy, antagonism, and what the chequerboard puts between them
Odds, F. C. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg301 · Cited by 2,481
Antibacterial drug discovery in the resistance era
Brown, E. D., & Wright, G. D. (2016) · Nature · doi:10.1038/nature17042 · Cited by 2,247
Self-citationSystematic Genetic Analysis with Ordered Arrays of Yeast Deletion Mutants
Tong, A. H. Y., Evangelista, M., Parsons, A. B., Xu, H., Bader, G. D., Pagé, N., Robinson, M., Raghibizadeh, S., Hogue, C. W. V., Bussey, H., et al. (2001) · Science · doi:10.1126/science.1065810 · Cited by 2,138
Self-citationThree Decades of β-Lactamase Inhibitors
Drawz, S. M., & Bonomo, R. A. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00037-09 · Cited by 1,709
The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria
Li, X.-Z., Plésiat, P., & Nikaido, H. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00117-14 · Cited by 1,614
The search for synergy: a critical review from a response surface perspective.
Greco, W. R., Bravo, G., & Parsons, J. C. (1995) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06847-4 · Cited by 1,434
β-Lactams and β-Lactamase Inhibitors: An Overview
Bush, K., & Bradford, P. A. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025247 · Cited by 1,412
Challenges of Antibacterial Discovery
Silver, L. L. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00030-10 · Cited by 1,376
Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework
Cook, D., Brown, D., Alexander, R., March, R., Morgan, P., Satterthwaite, G., & Pangalos, M. N. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4309 · Cited by 1,344
A global genetic interaction network maps a wiring diagram of cellular function
Costanzo, M., VanderSluis, B., Koch, E. N., Baryshnikova, A., Pons, C., Tan, G., Wang, W., Usaj, M., Hanchard, J., Lee, S. D., et al. (2016) · Science · doi:10.1126/science.aaf1420 · Cited by 1,240
Interaction network containing conserved and essential protein complexes in Escherichia coli
Butland, G., Peregrín-Alvarez, J. M., Li, J., Yang, W., Yang, X., Canadien, V., Starostine, A., Richards, D., Beattie, B., Krogan, N., et al. (2005) · Nature · doi:10.1038/nature03239 · Cited by 1,201
DeepARG: a deep learning approach for predicting antibiotic resistance genes from metagenomic data
Arango-Argoty, G., Garner, E., Pruden, A., Heath, L. S., Vikesland, P., & Zhang, L. (2018) · Microbiome · doi:10.1186/s40168-018-0401-z · Cited by 958
Bacterial Resistance to β-Lactam Antibiotics: Compelling Opportunism, Compelling Opportunity
Fisher, J. F., Meroueh, S. O., & Mobashery, S. (2005) · Chemical Reviews · doi:10.1021/cr030102i · Cited by 913
Lomovskaya, O., Warren, M. S., Lee, A., Galazzo, J., Fronko, R., Lee, M., Blais, J., Cho, D., Chamberland, S., Renau, T., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.1.105-116.2001 · Cited by 903
Automated design of ligands to polypharmacological profiles
Besnard, J., Ruda, G. F., Setola, V., Abecassis, K., Rodriguiz, R. M., Huang, X.-P., Norval, S., Sassano, M. F., Shin, A. I., Webster, L. A., et al. (2012) · Nature · doi:10.1038/nature11691 · Cited by 832
Principles for the buffering of genetic variation
Hartman, J. L., Garvik, B., & Hartwell, L. (2001) · Science · doi:10.1126/science.1056072 · Cited by 808
Principles for the Buffering of Genetic Variation
Hartman IV, J. L. (2001) · Science · doi:10.1126/science.291.5506.1001 · Cited by 808
Multicomponent therapeutics for networked systems
Keith, C. T., Borisy, A. A., & Stockwell, B. R. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1609 · Cited by 769
Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria
Nikaido, H., & Pagès, J.-M. (2012) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00290.x · Cited by 769
Stermitz, F. R., Lorenz, P., Tawara, J. N., Zenewicz, L. A., & Lewis, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.030540597 · Cited by 761
Analysis of a genome-wide set of gene deletions in the fission yeast Schizosaccharomyces pombe
Kim, D.-U., Hayles, J., Kim, D., Wood, V., Park, H.-O., Won, M., Yoo, H.-S., Duhig, T., Nam, M., Palmer, G., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1628 · Cited by 742
Multidrug evolutionary strategies to reverse antibiotic resistance
Baym, M., Stone, L. K., & Kishony, R. (2016) · Science · doi:10.1126/science.aad3292 · Cited by 710
Combination approaches to combat multidrug-resistant bacteria
Worthington, R. J., & Melander, C. (2013) · Trends in Biotechnology · doi:10.1016/j.tibtech.2012.12.006 · Cited by 625
ESKAPEing the labyrinth of antibacterial discovery
Tommasi, R., Brown, D. G., Walkup, G. K., Manchester, J. I., & Miller, A. A. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4572 · Cited by 608
Antibiotic Adjuvants: Rescuing Antibiotics from Resistance
Wright, G. D. (2016) · Trends in Microbiology · doi:10.1016/j.tim.2016.06.009 · Cited by 604
Self-citationChallis, G. L., & Hopwood, D. A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1934677100 · Cited by 597
Mutant phenotypes for thousands of bacterial genes of unknown function
Price, M. N., Wetmore, K. M., Waters, R. J., Callaghan, M., Ray, J., Liu, H., Kuehl, J. V., Melnyk, R. A., Lamson, J. S., Suh, Y., et al. (2018) · Nature · doi:10.1038/s41586-018-0124-0 · Cited by 576
Aspergillomarasmine A overcomes metallo-β-lactamase antibiotic resistance
King, A. M., Reid-Yu, S. A., Wang, W., King, D. T., De Pascale, G., Strynadka, N. C., Walsh, T. R., Coombes, B. K., & Wright, G. D. (2014) · Nature · doi:10.1038/nature13445 · Cited by 554
Self-citationBacterial efflux pump inhibitors from natural sources
Stavri, M., Piddock, L. J. V., & Gibbons, S. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl460 · Cited by 547
Modulating immunity as a therapy for bacterial infections
Hancock, R. E. W., Nijnik, A., & Philpott, D. J. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2745 · Cited by 535
Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy
Ejim, L., Farha, M. A., Falconer, S. B., Wildenhain, J., Coombes, B. K., Tyers, M., Brown, E. D., & Wright, G. D. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.559 · Cited by 525
Self-citationTrimethoprim and sulfonamide resistance.
Huovinen, P., Sundström, L., Swedberg, G., & Sköld, O. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.2.279 · Cited by 523
TRIMETHOPRIM, A SULPHONAMIDE POTENTIATOR
BUSHBY, S. R. M., & HITCHINGS, G. H. (1968) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1968.tb00475.x · Cited by 466
Antibiotic interactions that select against resistance
Chait, R., Craney, A., & Kishony, R. (2007) · Nature · doi:10.1038/nature05685 · Cited by 439
Dobzhansky, T. (1946) · Genetics · doi:10.1093/genetics/31.3.269 · Cited by 427
Naturally-occurring beta-lactamase inhibitors with antibacterial activity
BROWN, A. G., BUTTERWORTH, D., COLE, M., HANSCOMB, G., HOOD, J. D., READING, C., & ROLINSON, G. N. (1976) · The Journal of Antibiotics · doi:10.7164/antibiotics.29.668 · Cited by 399
Genotype to Phenotype: A Complex Problem
Dowell, R. D., Ryan, O., Jansen, A., Cheung, D., Agarwala, S., Danford, T., Bernstein, D. A., Rolfe, P. A., Heisler, L. E., Chin, B., et al. (2010) · Science · doi:10.1126/science.1189015 · Cited by 396
Symbiotic streptomycetes provide antibiotic combination prophylaxis for wasp offspring
Kroiss, J., Kaltenpoth, M., Schneider, B., Schwinger, M.-G., Hertweck, C., Maddula, R. K., Strohm, E., & Svatoš, A. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.331 · Cited by 389
Fluoroquinolone resistance protein NorA of Staphylococcus aureus is a multidrug efflux transporter
Neyfakh, A. A., Borsch, C. M., & Kaatz, G. W. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.1.128 · Cited by 361
Antibiotic resistance breakers: can repurposed drugs fill the antibiotic discovery void?
Brown, D. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4675 · Cited by 359
Species-specific activity of antibacterial drug combinations
Brochado, A. R., Telzerow, A., Bobonis, J., Banzhaf, M., Mateus, A., Selkrig, J., Huth, E., Bassler, S., Zamarreño Beas, J., Zietek, M., et al. (2018) · Nature · doi:10.1038/s41586-018-0278-9 · Cited by 357
Opportunities for natural products in 21st century antibiotic discovery
Wright, G. D. (2017) · Natural Product Reports · doi:10.1039/c7np00019g · Cited by 343
Self-citationStokes, J. M., MacNair, C. R., Ilyas, B., French, S., Côté, J.-P., Bouwman, C., Farha, M. A., Sieron, A. O., Whitfield, C., Coombes, B. K., et al. (2017) · Nature Microbiology · doi:10.1038/nmicrobiol.2017.28 · Cited by 340
Current status and prospects of HIV treatment
Cihlar, T., & Fordyce, M. (2016) · Current Opinion in Virology · doi:10.1016/j.coviro.2016.03.004 · Cited by 337
A community computational challenge to predict the activity of pairs of compounds
Community, N.-D., Bansal, M., Yang, J., Karan, C., Menden, M. P., Costello, J. C., Tang, H., Xiao, G., Li, Y., Allen, J., et al. (2014) · Nature Biotechnology · doi:10.1038/nbt.3052 · Cited by 321
Synthetic lethality: General principles, utility and detection using genetic screens in human cells
Nijman, S. M. B. (2011) · FEBS Letters · doi:10.1016/j.febslet.2010.11.024 · Cited by 319
Antibiotic Adjuvants: Diverse Strategies for Controlling Drug‐Resistant Pathogens
Gill, E. E., Franco, O. L., & Hancock, R. E. W. (2015) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12478 · Cited by 319
Systematic exploration of synergistic drug pairs
Cokol, M., Chua, H. N., Tasan, M., Mutlu, B., Weinstein, Z. B., Suzuki, Y., Nergiz, M. E., Costanzo, M., Baryshnikova, A., Giaever, G., et al. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.71 · Cited by 315
Multi-targeting by monotherapeutic antibacterials
Silver, L. L. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2202 · Cited by 311
Accelerated evolution of resistance in multidrug environments
Hegreness, M., Shoresh, N., Damian, D., Hartl, D., & Kishony, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805965105 · Cited by 300
A Broad-Spectrum Antibiofilm Peptide Enhances Antibiotic Action against Bacterial Biofilms
Reffuveille, F., de la Fuente-Núñez, C., Mansour, S., & Hancock, R. E. W. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03163-14 · Cited by 293
Lamers, R. P., Cavallari, J. F., & Burrows, L. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060666 · Cited by 291
Overcoming mcr-1 mediated colistin resistance with colistin in combination with other antibiotics
MacNair, C. R., Stokes, J. M., Carfrae, L. A., Fiebig-Comyn, A. A., Coombes, B. K., Mulvey, M. R., & Brown, E. D. (2018) · Nature Communications · doi:10.1038/s41467-018-02875-z · Cited by 287
Liu, A., Tran, L., Becket, E., Lee, K., Chinn, L., Park, E., Tran, K., & Miller, J. H. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00906-09 · Cited by 286
Emerging and evolving concepts in gene essentiality
Rancati, G., Moffat, J., Typas, A., & Pavelka, N. (2018) · Nature Reviews Genetics · doi:10.1038/nrg.2017.74 · Cited by 277
Systematic analysis of complex genetic interactions
Kuzmin, E., VanderSluis, B., Wang, W., Tan, G., Deshpande, R., Chen, Y., Usaj, M., Balint, A., Mattiazzi Usaj, M., van Leeuwen, J., et al. (2018) · Science · doi:10.1126/science.aao1729 · Cited by 277
Recover the lost art of drug discovery
Lewis, K. (2012) · Nature · doi:10.1038/485439a · Cited by 276
Yang, J. H., Bhargava, P., McCloskey, D., Mao, N., Palsson, B. O., & Collins, J. J. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.10.020 · Cited by 267
Alternating antibiotic treatments constrain evolutionary paths to multidrug resistance
Kim, S., Lieberman, T. D., & Kishony, R. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1409800111 · Cited by 264
Antibiotic adjuvants – A strategy to unlock bacterial resistance to antibiotics
González-Bello, C. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.08.027 · Cited by 254
The Origin of Variations in Sexual and Sex-Limited Characters
Bridges, C. B. (1922) · The American Naturalist · doi:10.1086/279847 · Cited by 250
Antibiotic adjuvants: multicomponent anti-infective strategies
Kalan, L., & Wright, G. D. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399410001766 · Cited by 249
Self-citationHierarchical Modularity and the Evolution of Genetic Interactomes across Species
Ryan, C. J., Roguev, A., Patrick, K., Xu, J., Jahari, H., Tong, Z., Beltrao, P., Shales, M., Qu, H., Collins, S. R., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.05.028 · Cited by 232
The synthetic genetic interaction spectrum of essential genes
Davierwala, A. P., Haynes, J., Li, Z., Brost, R. L., Robinson, M. D., Yu, L., Mnaimneh, S., Ding, H., Zhu, H., Chen, Y., et al. (2005) · Nature Genetics · doi:10.1038/ng1640 · Cited by 222
Multiple Novel Inhibitors of the NorA Multidrug Transporter of Staphylococcus aureus
Markham, P. N., Westhaus, E., Klyachko, K., Johnson, M. E., & Neyfakh, A. A. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.10.2404 · Cited by 218
Inhibition of WTA Synthesis Blocks the Cooperative Action of PBPs and Sensitizes MRSA to β-Lactams
Farha, M. A., Leung, A., Sewell, E. W., D’Elia, M. A., Allison, S. E., Ejim, L., Pereira, P. M., Pinho, M. G., Wright, G. D., & Brown, E. D. (2013) · ACS Chemical Biology · doi:10.1021/cb300413m · Cited by 216
Self-citationSjuts, H., Vargiu, A. V., Kwasny, S. M., Nguyen, S. T., Kim, H.-S., Ding, X., Ornik, A. R., Ruggerone, P., Bowlin, T. L., Nikaido, H., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1602472113 · Cited by 207
Dixon, S. J., Fedyshyn, Y., Koh, J. L. Y., Prasad, T. S. K., Chahwan, C., Chua, G., Toufighi, K., Baryshnikova, A., Hayles, J., Hoe, K.-L., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806261105 · Cited by 205
Kerantzas, C. A., & Jacobs, W. R. (2017) · mBio · doi:10.1128/mbio.01586-16 · Cited by 202
What is an “ideal” antibiotic? Discovery challenges and path forward
Singh, S. B., Young, K., & Silver, L. L. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.01.003 · Cited by 201
Takatsuka, Y., Chen, C., & Nikaido, H. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001460107 · Cited by 196
Cross‐species discovery of syncretic drug combinations that potentiate the antifungal fluconazole
Spitzer, M., Griffiths, E., Blakely, K. M., Wildenhain, J., Ejim, L., Rossi, L., De Pascale, G., Curak, J., Brown, E., Tyers, M., et al. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.31 · Cited by 183
Self-citationCombination antibiotic therapy for multidrug-resistant Gram-negative bacteria
Tängdén, T. (2014) · Upsala Journal of Medical Sciences · doi:10.3109/03009734.2014.899279 · Cited by 182
Kern, W. V., Steinke, P., Schumacher, A., Schuster, S., Baum, H. V., & Bohnert, J. A. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki445 · Cited by 172
Covington, B. C., MCLEAN, J. A. J., & Bachmann, B. O. (2016) · Natural Product Reports · doi:10.1039/c6np00048g · Cited by 168
Functional Repurposing Revealed by Comparing S. pombe and S. cerevisiae Genetic Interactions
Frost, A., Elgort, M. G., Brandman, O., Ives, C., Collins, S. R., Miller-Vedam, L., Weibezahn, J., Hein, M. Y., Poser, I., Mann, M., et al. (2012) · Cell · doi:10.1016/j.cell.2012.04.028 · Cited by 165
Optimal Drug Synergy in Antimicrobial Treatments
Torella, J. P., Chait, R., & Kishony, R. (2010) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000796 · Cited by 162
A Common Platform for Antibiotic Dereplication and Adjuvant Discovery
Cox, G., Sieron, A. O., King, A. M., Pascale, G. D., Pawlowski, A. C., Koteva, K. K., & Wright, G. D. (2016) · Cell chemical biology · doi:10.1016/j.chembiol.2016.11.011 · Cited by 160
Self-citationSystems-level antimicrobial drug and drug synergy discovery
Roemer, T., & Boone, C. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1205 · Cited by 159
The Combined Action of Penicillin with Streptomycin or Chloromycetin on Enterococci in Vitro
Jawetz, E., Gunnison, J. B., & Coleman, V. R. (1950) · Science · doi:10.1126/science.111.2880.254 · Cited by 153
Predictive computational phenotyping and biomarker discovery using reference-free genome comparisons
Drouin, A., Giguère, S., Déraspe, M., Marchand, M., Tyers, M. D., Loo, V. G., Bourgault, A., Laviolette, F., & Corbeil, J. (2016) · BMC Genomics · doi:10.1186/s12864-016-2889-6 · Cited by 152
Self-citationWu, X., Li, Z., Li, X., Tian, Y., Fan, Y., Yu, C., Zhou, B., Liu, Y., Xiang, R., & Yang, L. (2017) · Drug Design Development and Therapy · doi:10.2147/dddt.s107195 · Cited by 150
Babu, M., Arnold, R. R., Bundalovic-Torma, C., Gagarinova, A. G., Wong, K. S., Kumar, A., Stewart, G., Samanfar, B., Aoki, H., Wagih, O. M., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004120 · Cited by 147
Targeting the Adaptability of Heterogeneous Aneuploids
Chen, G., Mulla, W. A., Kucharavy, A., Tsai, H.-J., RUBINSTEIN, B. Y., Conkright, J. J., McCroskey, S., Bradford, W. D., Weems, L., Haug, J. S., et al. (2015) · Cell · doi:10.1016/j.cell.2015.01.026 · Cited by 140
Discovery of Wall Teichoic Acid Inhibitors as Potential Anti-MRSA β-Lactam Combination Agents
Wang, H., Gill, C., Lee, S. H., Mann, P. A., Zuck, P. D., Meredith, T. C., Murgolo, N., She, X., Kales, S., Liang, L., et al. (2013) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.11.013 · Cited by 136
Chemogenomics and orthology‐based design of antibiotic combination therapies
Chandrasekaran, S., Çakmak, M. Ç., Sahin, N., Yılancıoğlu, K., Kazan, H., Collins, J. J., & Cokol, M. (2016) · Molecular Systems Biology · doi:10.15252/msb.20156777 · Cited by 133
Prediction of Synergism from Chemical-Genetic Interactions by Machine Learning
Wildenhain, J., Spitzer, M., Dolma, S., Jarvik, N., White, R., Roy, M. M., Griffiths, E., Bellows, D. S., Wright, G. D., & Tyers, M. (2015) · Cell Systems · doi:10.1016/j.cels.2015.12.003 · Cited by 132
Self-citationSystems approaches and algorithms for discovery of combinatorial therapies
Feala, J. D., Cortes, J., Duxbury, P. M., Piermarocchi, C., McCulloch, A. D., & Paternostro, G. (2009) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.51 · Cited by 128
Abdali, N., Parks, J. M., Haynes, K. M., Chaney, J. L., Green, A. T., Wolloscheck, D., Walker, J. K., Rybenkov, V. V., Baudry, J. Y., Smith, J. C., et al. (2016) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.6b00167 · Cited by 127
Metabolic suppression identifies new antibacterial inhibitors under nutrient limitation
Zlitni, S., Ferruccio, L. F., & Brown, E. D. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1361 · Cited by 125
Novel Inhibitors of Erm Methyltransferases from NMR and Parallel Synthesis
Hajduk, P. J., Dinges, J., Schkeryantz, J. M., Janowick, D. A., Kaminski, M., Tufano, M. D., Augeri, D. J., Petros, A. M., Nienaber, V. L., Zhong, P., et al. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm990293a · Cited by 119
Inhibition of Aminoglycoside Antibiotic Resistance Enzymes by Protein Kinase Inhibitors
Daigle, D. M., McKay, G. A., & Wright, G. D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.40.24755 · Cited by 114
Self-citationLee, S. H., Wang, H., Labroli, M. A., Koseoglu, S., Zuck, P. D., Mayhood, T., Gill, C., Mann, P. A., Sher, X., Ha, S., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad7364 · Cited by 110
Antibiotic efficacy — context matters
Yang, J. H., Bening, S. C., & Collins, J. J. (2017) · Current Opinion in Microbiology · doi:10.1016/j.mib.2017.09.002 · Cited by 109
A map of directional genetic interactions in a metazoan cell
Fischer, B., Sandmann, T., Horn, T. L., Billmann, M., Chaudhary, V., Huber, W. K., & Boutros, M. (2015) · eLife · doi:10.7554/elife.05464 · Cited by 108
Farha, M. A., Czarny, T. L., Myers, C. L., Worrall, L. J., French, S., Conrady, D. G., Wang, Y., Oldfield, E., Strynadka, N. C. J., & Brown, E. D. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1511751112 · Cited by 104
From large networks to small molecules
Sharom, J. R., Bellows, D. S., & Tyers, M. (2003) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2003.12.007 · Cited by 103
Self-citationUses of polypills for cardiovascular disease and evidence to date
Huffman, M. D., Xavier, D., & Perel, P. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30553-6 · Cited by 103
Functional annotation of chemical libraries across diverse biological processes
Piotrowski, J. S., Li, S. C., Deshpande, R., Simpkins, S. W., Nelson, J., Yashiroda, Y., Barber, J. M., Safizadeh, H., Wilson, E. H., Okada, H., et al. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2436 · Cited by 102
Berditsch, M., Jäger, T., Strempel, N., Schwartz, T., Overhage, J., & Ulrich, A. S. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00682-15 · Cited by 101
Prevalence and patterns of higher-order drug interactions in Escherichia coli
Tekin, E., White, C., Kang, T. M., Singh, N. P., Cruz‐Loya, M., Damoiseaux, R. D., Savage, V. M., & Yeh, P. J. (2018) · npj Systems Biology and Applications · doi:10.1038/s41540-018-0069-9 · Cited by 97
Baeder, D. Y., Yu, G., Hozé, N., Rolff, J., & Regoes, R. R. (2016) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2015.0294 · Cited by 95
The Bicarbonate Transporter SLC4A7 Plays a Key Role in Macrophage Phagosome Acidification
Sedlyarov, V., Eichner, R., Girardi, E., Essletzbichler, P., Goldmann, U., Nunes, P., Srndic, I., Moskovskich, A., Heinz, L. X., Kartnig, F., et al. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.04.013 · Cited by 94
Broad-Spectrum Peptide Inhibitors of Aminoglycoside Antibiotic Resistance Enzymes
Boehr, D. D., Draker, K.-A., Koteva, K. K., Bains, M., Hancock, R. E. W., & Wright, G. D. (2003) · Chemistry & Biology · doi:10.1016/s1074-5521(03)00026-7 · Cited by 90
Self-citationWinter, S. V., Zychlinsky, A., & Bardoel, B. W. (2016) · Scientific Reports · doi:10.1038/srep24242 · Cited by 89
Inhibition of Bacterial Multidrug Resistance by Celecoxib, a Cyclooxygenase-2 Inhibitor
Kalle, A. M., & Rizvi, A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00735-10 · Cited by 83
Robbins, N., Spitzer, M., Yu, T., Cerone, R. P., Averette, A. K., Bahn, Y.-S., Heitman, J., Sheppard, D. C., Tyers, M., & Wright, G. D. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.10.018 · Cited by 78
Self-citationA Small Molecule Discrimination Map of the Antibiotic Resistance Kinome
Shakya, T., Stogios, P. J., Waglechner, N., Evdokimova, E., Ejim, L. J., Blanchard, J., McArthur, A. G., Savchenko, A. V., & Wright, G. D. (2011) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.10.018 · Cited by 78
Self-citationAntibacterial Antifolates: From Development through Resistance to the Next GenerationPreprint
Estrada, A., Wright, D. L., & Anderson, A. C. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a028324 · Cited by 78
Additivity of inhibitory effects in multidrug combinations
Russ, D., & Kishony, R. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0252-1 · Cited by 77
A Forward Chemical Screen Identifies Antibiotic Adjuvants in Escherichia coli
Taylor, P. L., Rossi, L., Pascale, G. D., & Wright, G. D. (2012) · ACS Chemical Biology · doi:10.1021/cb300269g · Cited by 74
Self-citationTekin, E., Beppler, C., White, C., Mao, Z., Savage, V. M., & Yeh, P. J. (2016) · Journal of The Royal Society Interface · doi:10.1098/rsif.2016.0332 · Cited by 71
7-Hydroxytropolone: an inhibitor of aminoglycoside-2"-O-adenylyltransferase
Allen, N. E., Alborn, W. E., Hobbs, J. N., & Kirst, H. A. (1982) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.22.5.824 · Cited by 70
Mann, P. A., Müller, A., Xiao, L., Pereira, P. M., Yang, C., Lee, S. H., Wang, H., Trzeciak, J., Schneeweis, J. E., dos Santos, M. M., et al. (2013) · ACS Chemical Biology · doi:10.1021/cb400487f · Cited by 69
A robust platform for chemical genomics in bacterial systems
French, S., Mangat, C. S., Bharat, A., Côté, J., Mori, H., & Brown, E. D. (2016) · Molecular Biology of the Cell · doi:10.1091/mbc.e15-08-0573 · Cited by 69
Bush, K. (2017) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.7b00243 · Cited by 69
Suppression of Emergence of Resistance in Pathogenic Bacteria: Keeping Our Powder Dry, Part 1
Drusano, G. L., Louie, A., MacGowan, A. P., & Hope, W. W. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02177-15 · Cited by 64
Wambaugh, M. A., Shakya, V. P. S., Lewis, A. J., Mulvey, M. A., & Brown, J. C. S. (2017) · PLOS Biology · doi:10.1371/journal.pbio.2001644 · Cited by 63
Hybrid antibiotics – clinical progress and novel designs
Parkes, A. L., & Yule, I. A. (2016) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2016.1187597 · Cited by 63
Rationale for use of antimicrobial combinations
Moellering, R. C. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)90088-8 · Cited by 62
Stogios, P. J., Spanogiannopoulos, P., Evdokimova, E., Egorova, O., Shakya, T., Todorovic, N., Capretta, A. A., Wright, G. D., & Savchenko, A. V. (2013) · Biochemical Journal · doi:10.1042/bj20130317 · Cited by 60
Self-citationMechanisms of resistance of Escherichia coli to sulfonamides
Pato, M. L., & Brown, G. M. (1963) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(63)90435-1 · Cited by 55
Suppression of Emergence of Resistance in Pathogenic Bacteria: Keeping Our Powder Dry, Part 2
Drusano, G. L., Hope, W. W., MacGowan, A. P., & Louie, A. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02231-15 · Cited by 55
Small Molecule Suppression of Carbapenem Resistance in NDM-1 Producing Klebsiella pneumoniae
Worthington, R. J., Bunders, C. A., Reed, C. S., & Melander, C. (2012) · ACS Medicinal Chemistry Letters · doi:10.1021/ml200290p · Cited by 50
Langlais, D., Fodil, N., & Gros, P. (2016) · Annual Review of Immunology · doi:10.1146/annurev-immunol-051116-052442 · Cited by 48
A macrophage-stimulating compound from a screen of microbial natural products
Perry, J. A., Koteva, K. K., Verschoor, C. P., Wang, W., Bowdish, D. M. E., & Wright, G. D. (2014) · The Journal of Antibiotics · doi:10.1038/ja.2014.83 · Cited by 47
Self-citationNetworks from drug–drug surfaces
Yeh, P. J., & Kishony, R. (2007) · Molecular Systems Biology · doi:10.1038/msb4100133 · Cited by 39
Tran, T. B., Cheah, S.-E., Yu, H. H., Bergen, P. J., Nation, R. L., Creek, D. J., Purcell, A. W., Forrest, A., Doi, Y., Song, J., et al. (2015) · The Journal of Antibiotics · doi:10.1038/ja.2015.127 · Cited by 37
Antibacterial synergism of novel antibiotic peptides with chloramphenicol
Park, Y., Kim, H. J., & Hahm, K. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.06.113 · Cited by 29
When more is less: Emergent suppressive interactions in three-drug combinations
Beppler, C., Tekin, E., White, C., Mao, Z., Miller, J. H., Damoiseaux, R. D., Savage, V. M., & Yeh, P. J. (2017) · BMC Microbiology · doi:10.1186/s12866-017-1017-3 · Cited by 28
A Hybrid Drug Limits Resistance by Evading the Action of the Multiple Antibiotic Resistance Pathway
Wang, K. K., Stone, L. K., Lieberman, T. D., Shavit, M., Baasov, T., & Kishony, R. (2015) · Molecular Biology and Evolution · doi:10.1093/molbev/msv243 · Cited by 27
Nguyen, T. V., Blackledge, M. S., Lindsey, E. A., Minrovic, B. M., Ackart, D. F., Jeon, A. B., Obregón‐Henao, A., Melander, R. J., Basaraba, R. J., & Melander, C. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201612006 · Cited by 27
Aziz, R. K., Monk, J. M., Lewis, R. M., Loh, S. I., Mishra, A., Nagle, A. A., Satyanarayana, C., Dhakshinamoorthy, S., Luche, M., Kitchen, D. B., et al. (2015) · Scientific Reports · doi:10.1038/srep16025 · Cited by 20
Brochmann, R. P., Helmfrid, A., Jana, B., Magnowska, Z., & Guardabassi, L. (2016) · BMC Veterinary Research · doi:10.1186/s12917-016-0751-3 · Cited by 20
Synergistic Antibiotic Combinations
Bush, K. (2017) · Topics in medicinal chemistry · doi:10.1007/7355_2017_23 · Cited by 20
Postma, N., Kiers, D., & Pickkers, P. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.11.001 · Cited by 19
Wildenhain, J., Spitzer, M., Dolma, S., Jarvik, N., White, R., Roy, M. M., Griffiths, E., Bellows, D. S., Wright, G. D., & Tyers, M. (2016) · Scientific Data · doi:10.1038/sdata.2016.95 · Cited by 18
Self-citationQuébatte, M., & Dehio, C. (2017) · Current Opinion in Microbiology · doi:10.1016/j.mib.2017.08.002 · Cited by 12
Cited by
Antimicrobial Resistance in ESKAPE Pathogens
De Oliveira, D. M. P., Forde, B. M., Kidd, T. J., Harris, P. N. A., Schembri, M. A., Beatson, S. A., Paterson, D. L., & Walker, M. J. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00181-19 · Cited by 2,078
Towards the sustainable discovery and development of new antibiotics
Miethke, M., Pieroni, M., Weber, T., Brönstrup, M., Hammann, P., Halby, L., Arimondo, P. B., Glaser, P., Aigle, B., Bode, H. B., et al. (2021) · Nature Reviews Chemistry · doi:10.1038/s41570-021-00313-1 · Cited by 1,151
Overcoming cancer therapeutic bottleneck by drug repurposing
Zhang, Z., Zhou, L., Xie, N., Nice, E. C., Zhang, T., Cui, Y., & Huang, C. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00213-8 · Cited by 516
Anti-tuberculosis treatment strategies and drug development: challenges and priorities
Dartois, V. A., & Rubin, E. J. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00731-y · Cited by 490
A Dual-Mechanism Antibiotic Kills Gram-Negative Bacteria and Avoids Drug Resistance
Martin, J. K., Sheehan, J. P., Bratton, B. P., Moore, G. M., Mateus, A., Li, S. H.-J., Kim, H., Rabinowitz, J. D., Typas, A., Savitski, M. M., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.005 · Cited by 356
Metadata
- Authors
- Tyers, M., & Wright, G. D.
- Venue
- Nature Reviews Microbiology
- Published
- 2019-01-25
- Volume
- 17
- Issue
- 3
- Pages
- 141-155
- ISSN
- 1740-1526 (ISSN-L)
- 1740-1534
- OpenAlex
- W2912247484
- Cited by
- 820
- References
- 149
- FWCI
- 10.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.